Chronic kidney disease after liver, cardiac, lung, heart–lung, and hematopoietic stem cell transplant

Patient survival after cardiac, liver, and hematopoietic stem cell transplant (HSCT) is improving; however, this survival is limited by substantial pretransplant and treatment-related toxicities. A major cause of morbidity and mortality after transplant is chronic kidney disease (CKD). Although the...

Descripción completa

Detalles Bibliográficos
Autor principal: Hingorani, Sangeeta
Formato: Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2008
Materias:
Educational Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2335288/
https://www.ncbi.nlm.nih.gov/pubmed/18414901
http://dx.doi.org/10.1007/s00467-008-0785-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2335288/
https://www.ncbi.nlm.nih.gov/pubmed/18414901
http://dx.doi.org/10.1007/s00467-008-0785-2

Ejemplares similares